Euthyrox 50 Merckgroup Overview
Euthyrox 50 Merckgroup is a pharmaceutical-grade L-thyroxine sodium preparation manufactured by Merck Group, representing one of the most widely studied thyroid hormone compounds in metabolic research. This synthetic form of thyroxine (T4) provides researchers with a standardised tool for investigating thyroid hormone pathways, cellular metabolism, and endocrine system interactions. Each tablet contains 50 micrograms of levothyroxine sodium, offering consistent dosing for laboratory protocols examining thyroid function, metabolic rate modulation, and hormone replacement therapy mechanisms.
The compound’s pharmaceutical manufacturing standards ensure high purity and stability, making it particularly valuable for researchers studying metabolic modulators and thyroid hormone biology. Scientists at Stroid UK Shop frequently incorporate Euthyrox 50 into protocols investigating energy expenditure, thermogenesis, and metabolic pathway activation. The standardised tablet format facilitates precise measurement and consistent experimental conditions across repeated studies.
Research Applications in Laboratory Studies
Laboratory investigations utilising Euthyrox 50 Merckgroup focus primarily on thyroid hormone receptor activation and downstream metabolic effects. Research applications include studying T4 to T3 conversion pathways, examining thyroid stimulating hormone feedback mechanisms, and evaluating cellular oxygen consumption changes following thyroid hormone exposure. The compound serves as a reference standard for investigating metabolic rate alterations and energy expenditure modifications in controlled laboratory environments.
Researchers examining compounds from our L-thyroxine sodium collection often combine Euthyrox 50 studies with investigations of selective androgen receptor modulators and peptide compounds to understand complex hormonal interactions. The compound’s well-characterised pharmacokinetic profile makes it valuable for comparative studies with other metabolic modulators and endocrine research compounds.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Compound | L-thyroxine sodium (levothyroxine sodium) |
| Strength | 50 micrograms per tablet |
| Manufacturer | Merck Group |
| Form | Oral tablets |
| CAS Number | 25416-65-3 |
| Molecular Formula | C₁₅H₁₀I₄NNaO₄ |
| Storage | Room temperature, dry conditions |
Research Compliance Statement
Euthyrox 50 Merckgroup is supplied exclusively for in-vitro laboratory research and analytical purposes. This pharmaceutical compound is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure appropriate safety protocols, proper handling procedures, and compliance with institutional research guidelines when utilising this thyroid hormone compound. All studies should be conducted under appropriate scientific oversight with proper documentation of experimental parameters and safety measures.
